Researchers advance CRISPR-based tool for diagnosing disease

The team that first unveiled the rapid, inexpensive, highly sensitive CRISPR-based diagnostic tool called SHERLOCK has greatly enhanced the tool’s power, and has developed a miniature paper test that allows results to be seen with the naked eye — without the need for expensive equipment.

 

The SHERLOCK team developed a simple paper strip to display test results for a single genetic signature, borrowing from the visual cues common in pregnancy tests. After dipping the paper strip into a processed sample, a line appears, indicating whether the target molecule was detected or not.

This new feature helps pave the way for field use, such as during an outbreak. The team has also increased the sensitivity of SHERLOCK and added the capacity to accurately quantify the amount of target in a sample and test for multiple targets at once. All together, these advancements accelerate SHERLOCK’s ability to quickly and precisely detect genetic signatures — including pathogens and tumor DNA — in samples.

Described today in Science, the innovations build on the team’s earlier version of SHERLOCK (shorthand for Specific High Sensitivity Reporter unLOCKing) and add to a growing field of research that harnesses CRISPR systems for uses beyond gene editing. The work, led by researchers from the Broad Institute of MIT and Harvard and from MIT, has the potential for a transformative effect on research and global public health.

“SHERLOCK provides an inexpensive, easy-to-use, and sensitive diagnostic method for detecting nucleic acid material — and that can mean a virus, tumor DNA, and many other targets,” said senior author Feng Zhang, a core institute member of the Broad Institute, an investigator at the McGovern Institute, and the James and Patricia Poitras ’63 Professor in Neuroscience and associate professor in the departments of Brain and Cognitive Sciences and Biological Engineering at MIT. “The SHERLOCK improvements now give us even more diagnostic information and put us closer to a tool that can be deployed in real-world applications.”

The researchers previously showcased SHERLOCK’s utility for a range of applications. In the new study, the team uses SHERLOCK to detect cell-free tumor DNA in blood samples from lung cancer patients and to detect synthetic Zika and Dengue virus simultaneously, in addition to other demonstrations.

Clear results on a paper strip

“The new paper readout for SHERLOCK lets you see whether your target was present in the sample, without instrumentation,” said co-first author Jonathan Gootenberg, a Harvard graduate student in Zhang’s lab as well as the lab of Broad core institute member Aviv Regev. “This moves us much closer to a field-ready diagnostic.”

The team envisions a wide range of uses for SHERLOCK, thanks to its versatility in nucleic acid target detection. “The technology demonstrates potential for many health care applications, including diagnosing infections in patients and detecting mutations that confer drug resistance or cause cancer, but it can also be used for industrial and agricultural applications where monitoring steps along the supply chain can reduce waste and improve safety,” added Zhang.

At the core of SHERLOCK’s success is a CRISPR-associated protein called Cas13, which can be programmed to bind to a specific piece of RNA. Cas13’s target can be any genetic sequence, including viral genomes, genes that confer antibiotic resistance in bacteria, or mutations that cause cancer. In certain circumstances, once Cas13 locates and cuts its specified target, the enzyme goes into overdrive, indiscriminately cutting other RNA nearby. To create SHERLOCK, the team harnessed this “off-target” activity and turned it to their advantage, engineering the system to be compatible with both DNA and RNA.

SHERLOCK’s diagnostic potential relies on additional strands of synthetic RNA that are used to create a signal after being cleaved. Cas13 will chop up this RNA after it hits its original target, releasing the signaling molecule, which results in a readout that indicates the presence or absence of the target.

Multiple targets and increased sensitivity

The SHERLOCK platform can now be adapted to test for multiple targets. SHERLOCK initially could only detect one nucleic acid sequence at a time, but now one analysis can give fluorescent signals for up to four different targets at once — meaning less sample is required to run through diagnostic panels. For example, the new version of SHERLOCK can determine in a single reaction whether a sample contains Zika or dengue virus particles, which both cause similar symptoms in patients. The platform uses Cas13 and Cas12a (previously known as Cpf1) enzymes from different species of bacteria to generate the additional signals.

SHERLOCK’s second iteration also uses an additional CRISPR-associated enzyme to amplify its detection signal, making the tool more sensitive than its predecessor. “With the original SHERLOCK, we were detecting a single molecule in a microliter, but now we can achieve 100-fold greater sensitivity,” explained co-first author Omar Abudayyeh, an MIT graduate student in Zhang’s lab at Broad. “That’s especially important for applications like detecting cell-free tumor DNA in blood samples, where the concentration of your target might be extremely low. This next generation of features help make SHERLOCK a more precise system.”

The authors have made their reagents available to the academic community through Addgene and their software tools can be accessed via the Zhang lab website and GitHub.

This study was supported in part by the National Institutes of Health and the Defense Threat Reduction Agency.

Beyond the 30 Million Word Gap

At the McGovern Institute for Brain Research at MIT, John Gabrieli’s lab is studying how exposure to language may influence brain function in children.

Back-and-forth exchanges boost children’s brain response to language

A landmark 1995 study found that children from higher-income families hear about 30 million more words during their first three years of life than children from lower-income families. This “30-million-word gap” correlates with significant differences in tests of vocabulary, language development, and reading comprehension.

MIT cognitive scientists have now found that conversation between an adult and a child appears to change the child’s brain, and that this back-and-forth conversation is actually more critical to language development than the word gap. In a study of children between the ages of 4 and 6, they found that differences in the number of “conversational turns” accounted for a large portion of the differences in brain physiology and language skills that they found among the children. This finding applied to children regardless of parental income or education.

The findings suggest that parents can have considerable influence over their children’s language and brain development by simply engaging them in conversation, the researchers say.

“The important thing is not just to talk to your child, but to talk with your child. It’s not just about dumping language into your child’s brain, but to actually carry on a conversation with them,” says Rachel Romeo, a graduate student at Harvard and MIT and the lead author of the paper, which appears in the Feb. 14 online edition of Psychological Science.

Using functional magnetic resonance imaging (fMRI), the researchers identified differences in the brain’s response to language that correlated with the number of conversational turns. In children who experienced more conversation, Broca’s area, a part of the brain involved in speech production and language processing, was much more active while they listened to stories. This brain activation then predicted children’s scores on language assessments, fully explaining the income-related differences in children’s language skills.

“The really novel thing about our paper is that it provides the first evidence that family conversation at home is associated with brain development in children. It’s almost magical how parental conversation appears to influence the biological growth of the brain,” says John Gabrieli, the Grover M. Hermann Professor in Health Sciences and Technology, a professor of brain and cognitive sciences, a member of MIT’s McGovern Institute for Brain Research, and the senior author of the study.

Beyond the word gap

Before this study, little was known about how the “word gap” might translate into differences in the brain. The MIT team set out to find these differences by comparing the brain scans of children from different socioeconomic backgrounds.

As part of the study, the researchers used a system called Language Environment Analysis (LENA) to record every word spoken or heard by each child. Parents who agreed to have their children participate in the study were told to have their children wear the recorder for two days, from the time they woke up until they went to bed.

The recordings were then analyzed by a computer program that yielded three measurements: the number of words spoken by the child, the number of words spoken to the child, and the number of times that the child and an adult took a “conversational turn” — a back-and-forth exchange initiated by either one.

The researchers found that the number of conversational turns correlated strongly with the children’s scores on standardized tests of language skill, including vocabulary, grammar, and verbal reasoning. The number of conversational turns also correlated with more activity in Broca’s area, when the children listened to stories while inside an fMRI scanner.

These correlations were much stronger than those between the number of words heard and language scores, and between the number of words heard and activity in Broca’s area.

This result aligns with other recent findings, Romeo says, “but there’s still a popular notion that there’s this 30-million-word gap, and we need to dump words into these kids — just talk to them all day long, or maybe sit them in front of a TV that will talk to them. However, the brain data show that it really seems to be this interactive dialogue that is more strongly related to neural processing.”

The researchers believe interactive conversation gives children more of an opportunity to practice their communication skills, including the ability to understand what another person is trying to say and to respond in an appropriate way.

While children from higher-income families were exposed to more language on average, children from lower-income families who experienced a high number of conversational turns had language skills and Broca’s area brain activity similar to those of children who came from higher-income families.

“In our analysis, the conversational turn-taking seems like the thing that makes a difference, regardless of socioeconomic status. Such turn-taking occurs more often in families from a higher socioeconomic status, but children coming from families with lesser income or parental education showed the same benefits from conversational turn-taking,” Gabrieli says.

Taking action

The researchers hope their findings will encourage parents to engage their young children in more conversation. Although this study was done in children age 4 to 6, this type of turn-taking can also be done with much younger children, by making sounds back and forth or making faces, the researchers say.

“One of the things we’re excited about is that it feels like a relatively actionable thing because it’s specific. That doesn’t mean it’s easy for less educated families, under greater economic stress, to have more conversation with their child. But at the same time, it’s a targeted, specific action, and there may be ways to promote or encourage that,” Gabrieli says.

Roberta Golinkoff, a professor of education at the University of Delaware School of Education, says the new study presents an important finding that adds to the evidence that it’s not just the number of words children hear that is significant for their language development.

“You can talk to a child until you’re blue in the face, but if you’re not engaging with the child and having a conversational duet about what the child is interested in, you’re not going to give the child the language processing skills that they need,” says Golinkoff, who was not involved in the study. “If you can get the child to participate, not just listen, that will allow the child to have a better language outcome.”

The MIT researchers now hope to study the effects of possible interventions that incorporate more conversation into young children’s lives. These could include technological assistance, such as computer programs that can converse or electronic reminders to parents to engage their children in conversation.

The research was funded by the Walton Family Foundation, the National Institute of Child Health and Human Development, a Harvard Mind Brain Behavior Grant, and a gift from David Pun Chan.

Study reveals molecular mechanisms of memory formation

MIT neuroscientists have uncovered a cellular pathway that allows specific synapses to become stronger during memory formation. The findings provide the first glimpse of the molecular mechanism by which long-term memories are encoded in a region of the hippocampus called CA3.

The researchers found that a protein called Npas4, previously identified as a master controller of gene expression triggered by neuronal activity, controls the strength of connections between neurons in the CA3 and those in another part of the hippocampus called the dentate gyrus. Without Npas4, long-term memories cannot form.

“Our study identifies an experience-dependent synaptic mechanism for memory encoding in CA3, and provides the first evidence for a molecular pathway that selectively controls it,” says Yingxi Lin, an associate professor of brain and cognitive sciences and a member of MIT’s McGovern Institute for Brain Research.

Lin is the senior author of the study, which appears in the Feb. 8 issue of Neuron. The paper’s lead author is McGovern Institute research scientist Feng-Ju (Eddie) Weng.

Synaptic strength

Neuroscientists have long known that the brain encodes memories by altering the strength of synapses, or connections between neurons. This requires interactions of many proteins found in both presynaptic neurons, which send information about an event, and postsynaptic neurons, which receive the information.

Neurons in the CA3 region play a critical role in the formation of contextual memories, which are memories that link an event with the location where it took place, or with other contextual information such as timing or emotions. These neurons receive synaptic inputs from three different pathways, and scientists have hypothesized that one of these inputs, from the dentate gyrus, is critical for encoding new contextual memories. However, the mechanism of how this information is encoded was not known.

In a study published in 2011, Lin and colleagues found that Npas4, a gene that is turned on immediately following new experiences, appears to act as a master controller of the program of gene expression required for long-term memory formation. They also found that Npas4 is most active in the CA3 region of the hippocampus during learning. This activity was already known to be required for fast contextual learning, such is required during a type of task known as contextual fear conditioning. During the conditioning, mice receive a mild electric shock when they enter and explore a specific chamber. Within minutes, the mice learn to fear the chamber, and the next time they enter it, they freeze.

When the researchers knocked out the Npas4 gene, they found that mice could not remember the fearful event. They also found the same effect when they knocked out the gene just in the CA3 region of the hippocampus. Knocking it out in other parts of the hippocampus, however, had no effect on memory.

In the new study, the researchers explored in further detail how Npas4 exerts its effects. Lin’s lab had previously developed a method that makes it possible to fluorescently label CA3 neurons that are activated during this fear conditioning. Using the same fear conditioning process, the researchers showed that during learning, certain synaptic inputs to CA3 neurons are strengthened, but not others. Furthermore, this strengthening requires Npas4.

The inputs that are selectively strengthened come from another part of the hippocampus called the dentate gyrus. These signals convey information about the location where the fearful experience took place.

Without Npas4, synapses coming from the dentate gyrus to CA3 failed to strengthen, and the mice could not form memories of the event. Further experiments revealed that this strengthening is required specifically for memory encoding, not for retrieving memories already formed. The researchers also found that Npas4 loss did not affect synaptic inputs that CA3 neurons receive from other sources.

Kimberly Raab-Graham, an associate professor of physiology and pharmacology at Wake Forest University School of Medicine, says the researchers used an impressive variety of techniques to unequivocally show that contextual memory formation is tightly controlled by Npas4.

“The major finding of the study is that contextual memory is driven by a single circuit and comes down to a single transcription factor,” says Raab-Graham, who was not involved in the study. “When they knocked out the transcription factor, they removed contextual memory formation, and they could restore it by adding the transcription factor.”

Synapse maintenance

The researchers also identified one of the genes that Npas4 controls to exert this effect on synapse strength. This gene, known as plk2, is involved in shrinking postsynaptic structures. Npas4 turns on plk2, thereby reducing synapse size and strength. This suggests that Npas4 itself does not strengthen synapses, but maintains synapses in a state that allows them to be strengthened when necessary. Without Npas4, synapses become too strong and therefore cannot be induced to encode memories by further strengthening them.

“When you take out Npas4, the synaptic strength is almost saturated,” Lin says. “And then when learning takes place, although the memory-encoding cells can be fluorescently labeled, you no longer see the strengthening of those connections.”

In future work, Lin hopes to study how the circuit connecting the dentate gyrus to CA3 interacts with other pathways required for memory retrieval. “Somehow there’s some crosstalk between different pathways so that once the information is stored, it can be retrieved by the other inputs,” she says.

The research was funded by the National Institutes of Health, the James H. Ferry Fund, and a Swedish Brain Foundation Research Fellowship.

Distinctive brain pattern helps habits form

Our daily lives include hundreds of routine habits. Brushing our teeth, driving to work, or putting away the dishes are just a few of the tasks that our brains have automated to the point that we hardly need to think about them.

Although we may think of each of these routines as a single task, they are usually made up of many smaller actions, such as picking up our toothbrush, squeezing toothpaste onto it, and then lifting the brush to our mouth. This process of grouping behaviors together into a single routine is known as “chunking,” but little is known about how the brain groups these behaviors together.

MIT neuroscientists have now found that certain neurons in the brain are responsible for marking the beginning and end of these chunked units of behavior. These neurons, located in a brain region highly involved in habit formation, fire at the outset of a learned routine, go quiet while it is carried out, then fire again once the routine has ended.

This task-bracketing appears to be important for initiating a routine and then notifying the brain once it is complete, says Ann Graybiel, an Institute Professor at MIT, a member of the McGovern Institute for Brain Research, and the senior author of the study.

Nuné Martiros, a recent MIT PhD recipient who is now a postdoc at Harvard University, is the lead author of the paper, which appears in the Feb. 8 issue of Current Biology. Alexandra Burgess, a recent MIT graduate and technical associate at the McGovern Institute, is also an author of the paper.

Routine activation

Graybiel has previously shown that a part of the brain called the striatum, which is found in the basal ganglia, plays a major role in habit formation. Several years ago, she and her group found that neuron firing patterns in the striatum change as animals learn a new habit, such as turning to the right or left in a maze upon hearing a certain tone.

When the animal is just starting to learn the maze, these neurons fire continuously throughout the task. However, as the animal becomes better at making the correct turn to receive a reward, the firing becomes clustered at the very beginning of the task and at the very end. Once these patterns form, it becomes extremely difficult to break the habit.

However, these previous studies did not rule out other explanations for the pattern, including the possibility that it might be related to the motor commands required for the maze-running behavior. In the new study, Martiros and Graybiel set out to determine whether this firing pattern could be conclusively linked with the chunking of habitual behavior.

The researchers trained rats to press two levers in a particular sequence, for example, 1-2-2 or 2-1-2. The rats had to figure out what the correct sequence was, and if they did, they received a chocolate milk reward. It took several weeks for them to learn the task, and as they became more accurate, the researchers saw the same beginning-and-end firing patterns develop in the striatum that they had seen in their previous habit studies.

Because each rat learned a different sequence, the researchers could rule out the possibility that the patterns correspond to the motor input required to preform a particular series of movements. This offers strong evidence that the firing pattern corresponds specifically to the initiation and termination of a learned routine, the researchers say.

“I think this more or less proves that the development of bracketing patterns serves to package up a behavior that the brain — and the animals — consider valuable and worth keeping in their repertoire. It really is a high-level signal that helps to release that habit, and we think the end signal says the routine has been done,” Graybiel says.

Distinctive patterns

The researchers also discovered a distinct pattern in a set of inhibitory neurons in the striatum. Activity in these neurons, known as interneurons, displayed a strong inverse relationship with the activity of the excitatory neurons that produce the bracketing pattern.

“The interneurons were activated during the time when the rats were in the middle of performing the learned sequence, and could possibly be preventing the principal neurons from initiating another routine until the current one was finished. The discovery of this opposite activity by the interneurons also gets us one step closer to understanding how brain circuits can actually produce this pattern of activity,” Martiros says.

Graybiel’s lab is now investigating further how the interaction between these two groups of neurons helps to encode habitual behavior in the striatum.

The research was funded by the National Institutes of Health/National Institute of Mental Health, the Office of Naval Research, and a McGovern Institute Mark Gorenberg Fellowship.

Polina Anikeeva and Feng Zhang awarded 2018 Vilcek Prize

Polina Anikeeva, the Class of 1942 Associate Professor in the Department of Materials Science and Engineering and associate director of the Research Laboratory of Electronics, and Feng Zhang, the James and Patricia Poitras ’63 Professor in Neuroscience at the McGovern Institute, have each been awarded a 2018 Vilcek Prize for Creative Promise in Biomedical Science. Awarded annually by the Vilcek Foundation, the $50,000 prizes recognize younger immigrants who have demonstrated exceptional promise early in their careers.

“The Vilcek Prizes were established in appreciation of the immigrants who chose to dedicate their vision and talent to bettering American society,” says Rick Kinsel, president of the Vilcek Foundation. “This year’s prizewinners honor and continue that legacy with works of astounding, revolutionary importance.”

Polina Anikeeva, who was born in the former Soviet Union, earned her PhD in materials science and engineering at MIT in 2009 and now runs her own bioelectronics lab in the same department focused on the development of materials and devices that enable recording and manipulation of signaling processes within the nervous system. The Vilcek Foundation recognizes Anikeeva for “fashioning ingenious solutions to long-standing challenges in biomedical engineering” including the design of therapeutic devices for conditions such as Parkinson’s disease and spinal cord injury.

Feng Zhang, who is also a core member of the Broad Institute and an associate professor in the departments of Brain and Cognitive Sciences and Biological Engineering, is being recognized for his role in advancing optogenetics (a method for controlling brain activity with light) and developing molecular tools to edit the genome. Thanks to his leadership in inventing precise and efficient gene-editing technologies using CRISPR, Zhang’s work has resulted in a “growing array of applications, such as uncovering the genetic underpinnings of diseases, ushering in gene therapies to cure heritable diseases, and improving agriculture.” Zhang’s family immigrated to the United States from China when he was 11 years of age.

Anikeeva and Zhang will be among eight Vilcek prizewinners honored at an awards gala in New York City in April 2018.

The Vilcek Foundation was established in 2000 by Jan and Marica Vilcek, immigrants from the former Czechoslovakia. The mission of the foundation, to honor the contributions of immigrants to the United States and to foster appreciation of the arts and sciences, was inspired by the couple’s respective careers in biomedical science and art history, as well as their personal experiences and appreciation of the opportunities they received as newcomers to this country.

Institute launches the MIT Intelligence Quest

MIT today announced the launch of the MIT Intelligence Quest, an initiative to discover the foundations of human intelligence and drive the development of technological tools that can positively influence virtually every aspect of society.

The announcement was first made in a letter MIT President L. Rafael Reif sent to the Institute community.

At a time of rapid advances in intelligence research across many disciplines, the Intelligence Quest will encourage researchers to investigate the societal implications of their work as they pursue hard problems lying beyond the current horizon of what is known.

Some of these advances may be foundational in nature, involving new insight into human intelligence, and new methods to allow machines to learn effectively. Others may be practical tools for use in a wide array of research endeavors, such as disease diagnosis, drug discovery, materials and manufacturing design, automated systems, synthetic biology, and finance.

“Today we set out to answer two big questions, says President Reif. “How does human intelligence work, in engineering terms? And how can we use that deep grasp of human intelligence to build wiser and more useful machines, to the benefit of society?”

MIT Intelligence Quest: The Core and The Bridge

MIT is poised to lead this work through two linked entities within MIT Intelligence Quest. One of them, “The Core,” will advance the science and engineering of both human and machine intelligence. A key output of this work will be machine-learning algorithms. At the same time, MIT Intelligence Quest seeks to advance our understanding of human intelligence by using insights from computer science.

The second entity, “The Bridge” will be dedicated to the application of MIT discoveries in natural and artificial intelligence to all disciplines, and it will host state-of-the-art tools from industry and research labs worldwide.

The Bridge will provide a variety of assets to the MIT community, including intelligence technologies, platforms, and infrastructure; education for students, faculty, and staff about AI tools; rich and unique data sets; technical support; and specialized hardware.

Along with developing and advancing the technologies of intelligence, MIT Intelligence Quest researchers will also investigate the societal and ethical implications of advanced analytical and predictive tools. There are already active projects and groups at the Institute investigating autonomous systems, media and information quality, labor markets and the work of the future, innovation and the digital economy, and the role of AI in the legal system.

In all its activities, MIT Intelligence Quest is intended to take advantage of — and strengthen — the Institute’s culture of collaboration. MIT Intelligence Quest will connect and amplify existing excellence across labs and centers already engaged in intelligence research. It will also establish shared, central spaces conducive to group work, and its resources will directly support research.

“Our quest is meant to power world-changing possibilities,” says Anantha Chandrakasan, dean of the MIT School of Engineering and Vannevar Bush Professor of Electrical Engineering and Computer Science. Chandrakasan, in collaboration with Provost Martin Schmidt and all four of MIT’s other school deans, has led the development and establishment of MIT Intelligence Quest.

“We imagine preventing deaths from cancer by using deep learning for early detection and personalized treatment,” Chandrakasan continues. “We imagine artificial intelligence in sync with, complementing, and assisting our own intelligence. And we imagine every scientist and engineer having access to human-intelligence-inspired algorithms that open new avenues of discovery in their fields. Researchers across our campus want to push the boundaries of what’s possible.”

Engaging energetically with partners

In order to power MIT Intelligence Quest and achieve results that are consistent with its ambitions, the Institute will raise financial support through corporate sponsorship and philanthropic giving.

MIT Intelligence Quest will build on the model that was established with the MIT–IBM Watson AI Lab, which was announced in September 2017. MIT researchers will collaborate with each other and with industry on challenges that range in scale from the very broad to the very specific.

“In the short time since we began our collaboration with IBM, the lab has garnered tremendous interest inside and outside MIT, and it will be a vital part of MIT Intelligence Quest,” says President Reif.

John E. Kelly III, IBM senior vice president for cognitive solutions and research, says, “To take on the world’s greatest challenges and seize its biggest opportunities, we need to rapidly advance both AI technology and our understanding of human intelligence. Building on decades of collaboration — including our extensive joint MIT–IBM Watson AI Lab — IBM and MIT will together shape a new agenda for intelligence research and its applications. We are proud to be a cornerstone of this expanded initiative.”

MIT will seek to establish additional entities within MIT Intelligence Quest, in partnership with corporate and philanthropic organizations.

Why MIT

MIT has been on the frontier of intelligence research since the 1950s, when pioneers Marvin Minsky and John McCarthy helped establish the field of artificial intelligence.

MIT now has over 200 principal investigators whose research bears directly on intelligence. Researchers at MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL) and the MIT Department of Brain and Cognitive Sciences (BCS) — along with the McGovern Institute for Brain Research and the Picower Institute for Learning and Memory — collaborate on a range of projects. MIT is also home to the National Science Foundation–funded center for Brains, Minds and Machines (CBMM) — the only national center of its kind.

Four years ago, MIT launched the Institute for Data, Systems, and Society (IDSS) with a mission promoting data science, particularly in the context of social systems. It is  anticipated that faculty and students from IDSS will play a critical role in this initiative.

Faculty from across the Institute will participate in the initiative, including researchers in the Media Lab, the Operations Research Center, the Sloan School of Management, the School of Architecture and Planning, and the School of Humanities, Arts, and Social Sciences.

“Our quest will amount to a journey taken together by all five schools at MIT,” says Provost Schmidt. “Success will rest on a shared sense of purpose and a mix of contributions from a wide variety of disciplines. I’m excited by the new thinking we can help unlock.”

At the heart of MIT Intelligence Quest will be collaboration among researchers in human and artificial intelligence.

“To revolutionize the field of artificial intelligence, we should continue to look to the roots of intelligence: the brain,” says James DiCarlo, department head and Peter de Florez Professor of Neuroscience in the Department of Brain and Cognitive Sciences. “By working with engineers and artificial intelligence researchers, human intelligence researchers can build models of the brain systems that produce intelligent behavior. The time is now, as model building at the scale of those brain systems is now possible. Discovering how the brain works in the language of engineers will not only lead to transformative AI — it will also illuminate entirely new ways to repair, educate, and augment our own minds.”

Daniela Rus, the Andrew (1956) and Erna Viterbi Professor of Electrical Engineering and Computer Science at MIT, and director of CSAIL, agrees. MIT researchers, she says, “have contributed pioneering and visionary solutions for intelligence since the beginning of the field, and are excited to make big leaps to understand human intelligence and to engineer significantly more capable intelligent machines. Understanding intelligence will give us the knowledge to understand ourselves and to create machines that will support us with cognitive and physical work.”

David Siegel, who earned a PhD in computer science at MIT in 1991 pursuing research at MIT’s Artificial Intelligence Laboratory, and who is a member of the MIT Corporation and an advisor to the MIT Center for Brains, Minds, and Machines, has been integral to the vision and formation of MIT Intelligence Quest and will continue to help shape the effort. “Understanding human intelligence is one of the greatest scientific challenges,” he says, “one that helps us understand who we are while meaningfully advancing the field of artificial intelligence.” Siegel is co-chairman and a founder of Two Sigma Investments, LP.

The fruits of research

MIT Intelligence Quest will thus provide a platform for long-term research, encouraging the foundational advances of the future. At the same time, MIT professors and researchers may develop technologies with near-term value, leading to new kinds of collaborations with existing companies — and to new companies.

Some such entrepreneurial efforts could be supported by The Engine, an Institute initiative launched in October 2016 to support startup companies pursuing particularly ambitious goals.

Other innovations stemming from MIT Intelligence Quest could be absorbed into the innovation ecosystem surrounding the Institute — in Kendall Square, Cambridge, and the Boston metropolitan area. MIT is located in close proximity to a world-leading nexus of biotechnology and medical-device research and development, as well as a cluster of leading-edge technology firms that study and deploy machine intelligence.

MIT also has roots in centers of innovation elsewhere in the United States and around the world, through faculty research projects, institutional and industry collaborations, and the activities and leadership of its alumni. MIT Intelligence Quest will seek to connect to innovative companies and individuals who share MIT’s passion for work in intelligence.

Eric Schmidt, former executive chairman of Alphabet, has helped MIT form the vision for MIT Intelligence Quest. “Imagine the good that can be done by putting novel machine-learning tools in the hands of those who can make great use of them,” he says. “MIT Intelligence Quest can become a fount of exciting new capabilities.”

“I am thrilled by today’s news,” says President Reif. “Drawing on MIT’s deep strengths and signature values, culture, and history, MIT Intelligence Quest promises to make important contributions to understanding the nature of intelligence, and to harnessing it to make a better world.”

“MIT is placing a bet,” he says, “on the central importance of intelligence research to meeting the needs of humanity.”

Ultrathin needle can deliver drugs directly to the brain

MIT researchers have devised a miniaturized system that can deliver tiny quantities of medicine to brain regions as small as 1 cubic millimeter. This type of targeted dosing could make it possible to treat diseases that affect very specific brain circuits, without interfering with the normal function of the rest of the brain, the researchers say.

Using this device, which consists of several tubes contained within a needle about as thin as a human hair, the researchers can deliver one or more drugs deep within the brain, with very precise control over how much drug is given and where it goes. In a study of rats, they found that they could deliver targeted doses of a drug that affects the animals’ motor function.

“We can infuse very small amounts of multiple drugs compared to what we can do intravenously or orally, and also manipulate behavioral changes through drug infusion,” says Canan Dagdeviren, the LG Electronics Career Development Assistant Professor of Media Arts and Sciences and the lead author of the paper, which appears in the Jan. 24 issue of Science Translational Medicine.

“We believe this tiny microfabricated device could have tremendous impact in understanding brain diseases, as well as providing new ways of delivering biopharmaceuticals and performing biosensing in the brain,” says Robert Langer, the David H. Koch Institute Professor at MIT and one of the paper’s senior authors.

Michael Cima, the David H. Koch Professor of Engineering in the Department of Materials Science and Engineering and a member of MIT’s Koch Institute for Integrative Cancer Research, is also a senior author of the paper.

Targeted action

Drugs used to treat brain disorders often interact with brain chemicals called neurotransmitters or the cell receptors that interact with neurotransmitters. Examples include l-dopa, a dopamine precursor used to treat Parkinson’s disease, and Prozac, used to boost serotonin levels in patients with depression. However, these drugs can have side effects because they act throughout the brain.

“One of the problems with central nervous system drugs is that they’re not specific, and if you’re taking them orally they go everywhere. The only way we can limit the exposure is to just deliver to a cubic millimeter of the brain, and in order to do that, you have to have extremely small cannulas,” Cima says.

The MIT team set out to develop a miniaturized cannula (a thin tube used to deliver medicine) that could target very small areas. Using microfabrication techniques, the researchers constructed tubes with diameters of about 30 micrometers and lengths up to 10 centimeters. These tubes are contained within a stainless steel needle with a diameter of about 150 microns. “The device is very stable and robust, and you can place it anywhere that you are interested,” Dagdeviren says.

The researchers connected the cannulas to small pumps that can be implanted under the skin. Using these pumps, the researchers showed that they could deliver tiny doses (hundreds of nanoliters) into the brains of rats. In one experiment, they delivered a drug called muscimol to a brain region called the substantia nigra, which is located deep within the brain and helps to control movement.

Previous studies have shown that muscimol induces symptoms similar to those seen in Parkinson’s disease. The researchers were able to generate those effects, which include stimulating the rats to continually turn in a clockwise direction, using their miniaturized delivery needle. They also showed that they could halt the Parkinsonian behavior by delivering a dose of saline through a different channel, to wash the drug away.

“Since the device can be customizable, in the future we can have different channels for different chemicals, or for light, to target tumors or neurological disorders such as Parkinson’s disease or Alzheimer’s,” Dagdeviren says.

This device could also make it easier to deliver potential new treatments for behavioral neurological disorders such as addiction or obsessive compulsive disorder, which may be caused by specific disruptions in how different parts of the brain communicate with each other.

“Even if scientists and clinicians can identify a therapeutic molecule to treat neural disorders, there remains the formidable problem of how to delivery the therapy to the right cells — those most affected in the disorder. Because the brain is so structurally complex, new accurate ways to deliver drugs or related therapeutic agents locally are urgently needed,” says Ann Graybiel, an MIT Institute Professor and a member of MIT’s McGovern Institute for Brain Research, who is also an author of the paper.

Measuring drug response

The researchers also showed that they could incorporate an electrode into the tip of the cannula, which can be used to monitor how neurons’ electrical activity changes after drug treatment. They are now working on adapting the device so it can also be used to measure chemical or mechanical changes that occur in the brain following drug treatment.

The cannulas can be fabricated in nearly any length or thickness, making it possible to adapt them for use in brains of different sizes, including the human brain, the researchers say.

“This study provides proof-of-concept experiments, in large animal models, that a small, miniaturized device can be safely implanted in the brain and provide miniaturized control of the electrical activity and function of single neurons or small groups of neurons. The impact of this could be significant in focal diseases of the brain, such as Parkinson’s disease,” says Antonio Chiocca, neurosurgeon-in-chief and chairman of the Department of Neurosurgery at Brigham and Women’s Hospital, who was not involved in the research.

The research was funded by the National Institutes of Health and the National Institute of Biomedical Imaging and Bioengineering.

The Beautiful Brain: The Drawings of Santiago Ramón y Cajal

Opening May 3, 2018

Santiago Ramón y Cajal made transformative discoveries of the anatomy of the brain and nervous system, work that led to his receiving a Nobel Prize in 1906. This founder of modern neuroscience was also an exceptional artist. His drawings of the brain were not only beautiful, but also astounding in their capacity to illustrate and understand the details of brain structure and function.

The Beautiful Brain: The Drawings of Santiago Ramón y Cajal at the MIT Museum is part of a traveling exhibit that will include approximately 80 of Cajal’s drawings, many rarely before seen in the U.S.

These historical works will be complimented by a contemporary exhibition of neuroscience visualizations that are leading to new insights, aided by technologies, many pioneered here at MIT’s McGovern Institute, that allow increasingly more detailed and precise understandings.

The exhibit is scheduled to open on May 3, 2018.


The Beautiful Brain: The Drawings of Santiago Ramón y Cajal was developed by the Frederick R. Weisman Art Museum, University of Minnesota with the CSIC’s Cajal Institute, Madrid, Spain.

wam_logos_4c-copy

 

 

 

 

 

Major exhibition support provided by:

ramondelpinocaixagreen

 

 

Sustaining exhibition support provided by:

cantabrialabs

 

 

 

 

 

Contributing exhibition support provided by:

spanishembassymibrpilm

 

bcslogostanleycenter

 

 

 

This exhibition is generously supported by the Associate Provost for the Arts, Philip Khoury. Additional support has been provided by the Council for the Arts at MIT.

CAMIT_Logo

 

 

 


 

School of Science Infinite Kilometer Awards for 2017

The MIT School of Science has announced the 2017 winners of the Infinite Kilometer Award. The Infinite Kilometer Award was established in 2012 to highlight and reward the extraordinary — but often underrecognized — work of the school’s research staff and postdocs.

Recipients of the award are exceptional contributors to their research programs. In many cases, they are also deeply committed to their local or global MIT community, and are frequently involved in mentoring and advising their junior colleagues, participating in the school’s educational programs, making contributions to the MIT Postdoctoral Association, or contributing to some other facet of the MIT community.

In addition to a monetary award, honorees and their colleagues, friends, and family are invited to a celebratory lunch in May.

The 2017 Infinite Kilometer winners are:

Rodrigo Garcia, McGovern Institute for Brain Research;

Lydia Herzel, Department of Biology;

Yutaro Iiyama, Laboratory for Nuclear Science;

Kendrick Jones, Picower Institute for Learning and Memory;

Matthew Musgrave, Laboratory for Nuclear Science;

Cody Siciliano, Picower Institute for Learning and Memory;

Peter Sudmant, Department of Biology;

Ashley Watson, Picower Institute for Learning and Memory;

The School of Science is also currently accepting nominations for its Infinite Mile Awards. Nominations are due by Feb. 16 and all School of Science employees are eligible. Infinite Mile Awards will be presented with the Infinite Kilometer Awards this spring.